Africa: Single-Dose Treatment for Sleeping Sickness Receives Approval
Acoziborole has been approved as a single-dose treatment for sleeping sickness, potentially simplifying treatment and aiding WHO's elimination efforts by 2030.
A compact global news feed for the bigger picture.
Acoziborole has been approved as a single-dose treatment for sleeping sickness, potentially simplifying treatment and aiding WHO's elimination efforts by 2030.
Loading Intelligence...
Select a report from the feed to view analysis and related coverage.
A compact global news feed for the bigger picture. It pulls reporting from outlets around the world so you can compare what gets covered, what gets missed, and how it’s framed.
It can feel dense at first (on purpose): more signal, less fluff. No ads. No trackers. No agenda.